These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Gene therapy for hemophilia: are viral vectors really feasible? Walsh C J Thromb Haemost; 2003 Feb; 1(2):218-9. PubMed ID: 12871491 [No Abstract] [Full Text] [Related]
25. Advances and challenges for hemophilia gene therapy. Batty P; Lillicrap D Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444 [TBL] [Abstract][Full Text] [Related]
26. The gene therapy journey for hemophilia: are we there yet? High KA Blood; 2012 Nov; 120(23):4482-7. PubMed ID: 22829631 [TBL] [Abstract][Full Text] [Related]
28. Hemophilia gene therapy: ushering in a new treatment paradigm? George LA Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):226-233. PubMed ID: 34889378 [TBL] [Abstract][Full Text] [Related]
29. Advances in gene therapy for hemophilia: basis, current status, and future perspectives. Ohmori T Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852 [TBL] [Abstract][Full Text] [Related]
30. Molecular biology of coagulation. Pavirani A; Bischoff R Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038 [No Abstract] [Full Text] [Related]
31. Preclinical and clinical gene therapy for haemophilia. Chuah MK; Collen D; Vandendriessche T Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Leebeek FWG; Miesbach W Blood; 2021 Sep; 138(11):923-931. PubMed ID: 34232980 [TBL] [Abstract][Full Text] [Related]
34. Gene therapy for hemophilia: Current status and laboratory consequences. Batty P; Lillicrap D Int J Lab Hematol; 2021 Jul; 43 Suppl 1():117-123. PubMed ID: 34288447 [TBL] [Abstract][Full Text] [Related]
35. The molecular genetics of hemophilia A and B in man. Factor VIII and factor IX deficiency. Antonarakis SE Adv Hum Genet; 1988; 17():27-59. PubMed ID: 3142226 [No Abstract] [Full Text] [Related]
36. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors. Monahan PE Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in the management of the child who has hemophilia. Dunn AL; Abshire TC Hematol Oncol Clin North Am; 2004 Dec; 18(6):1249-76, viii. PubMed ID: 15511615 [TBL] [Abstract][Full Text] [Related]
38. Gene Therapy in Hemophilia: Recent Advances. RodrÃguez-Merchán EC; De Pablo-Moreno JA; Liras A Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299267 [TBL] [Abstract][Full Text] [Related]
39. Gene transfer in the hemophilias: retrospect and prospect. Brinkhous KM Thromb Res; 1992 Aug; 67(3):329-38. PubMed ID: 1412215 [No Abstract] [Full Text] [Related]
40. Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives. Chernyi N; Gavrilova D; Saruhanyan M; Oloruntimehin ES; Karabelsky A; Bezsonov E; Malogolovkin A Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]